Photo from wikipedia
There is limited information regarding the effectiveness of endothelin receptor antagonists (ERA) in patients with connective tissue disease‐pulmonary arterial hypertension (CTD‐PAH), a condition that is characterized by poorer clinical outcomes… Click to show full abstract
There is limited information regarding the effectiveness of endothelin receptor antagonists (ERA) in patients with connective tissue disease‐pulmonary arterial hypertension (CTD‐PAH), a condition that is characterized by poorer clinical outcomes compared to other PAH subtypes.
Keywords:
connective tissue;
pulmonary arterial;
endothelin receptor;
tissue disease;
receptor antagonists;
arterial hypertension
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!